Afficher la notice abrégée

dc.creatorAppleton J.P., Woodhouse L.J., Bereczki D., Berge E., Christensen H.K., Collins R., Gommans J., Ntaios G., Ozturk S., Szatmari S., Wardlaw J.M., Sprigg N., Rothwell P.M., Bath P.M.en
dc.date.accessioned2023-01-31T07:32:41Z
dc.date.available2023-01-31T07:32:41Z
dc.date.issued2019
dc.identifier10.1161/STROKEAHA.118.023190
dc.identifier.issn00392499
dc.identifier.urihttp://hdl.handle.net/11615/70744
dc.description.abstractBackground and Purpose - Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcome in participants in the ENOS trial (Efficacy of Nitric Oxide in Stroke). Methods - Four thousand and eleven patients with acute stroke and raised BP were randomized within 48 hours of onset to transdermal GTN or no GTN for 7 days. Peripheral hemodynamics were measured at baseline (3 measures) and daily (2 measures) during treatment. Between-visit BP variability over days 1 to 7 (as SD) was assessed in quintiles. Functional outcome was assessed as modified Rankin Scale and cognition as telephone mini-mental state examination at day 90. Analyses were adjusted for baseline prognostic variables. Data are mean difference or odds ratios with 95% CI. Results - Increased baseline BP (diastolic, variability), heart rate, and rate-pressure product were each associated with unfavorable functional outcome at day 90. Increased between-visit systolic BP variability was associated with an unfavourable shift in modified Rankin Scale (highest quintile adjusted odds ratio, 1.65; 95% CI, 1.37-1.99), worse cognitive scores (telephone mini-mental state examination: highest quintile adjusted mean difference, -2.03; 95% CI, -2.84 to -1.22), and increased odds of death at day 90 (highest quintile adjusted odds ratio, 1.57; 95% CI, 1.12-2.19). GTN lowered BP and rate-pressure product and increased heart rate at day 1 and reduced between-visit systolic BP variability. Conclusions - Increased between-visit BP variability was associated with poor functional and cognitive outcomes and increased death 90 days after acute stroke. In addition to lowering BP and rate-pressure product, GTN reduced between-visit systolic BP variability. Agents that lower BP variability in acute stroke require further study. © 2019 International Anesthesia Research Society.en
dc.language.isoenen
dc.sourceStrokeen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85060618727&doi=10.1161%2fSTROKEAHA.118.023190&partnerID=40&md5=395fb7249198077ec9dff70faaf73868
dc.subjectantihypertensive agenten
dc.subjectglyceryl trinitrateen
dc.subjectnitric oxideen
dc.subjectglyceryl trinitrateen
dc.subjectageden
dc.subjectArticleen
dc.subjectblood pressure measurementen
dc.subjectcerebrovascular accidenten
dc.subjectcognitionen
dc.subjectcontrolled studyen
dc.subjectdrug effecten
dc.subjectelevated blood pressureen
dc.subjectfemaleen
dc.subjectfunctional assessmenten
dc.subjectheart rateen
dc.subjecthemodynamicsen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectpriority journalen
dc.subjectpulse pressureen
dc.subjectrandomized controlled trialen
dc.subjectRankin scaleen
dc.subjectsecondary analysisen
dc.subjectsystolic blood pressureen
dc.subjectacute diseaseen
dc.subjectblood pressureen
dc.subjectclinical trialen
dc.subjectcutaneous drug administrationen
dc.subjectmiddle ageden
dc.subjectmortalityen
dc.subjectmulticenter studyen
dc.subjectpathophysiologyen
dc.subjecttime factoren
dc.subjectvery elderlyen
dc.subjectAcute Diseaseen
dc.subjectAdministration, Cutaneousen
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectBlood Pressureen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNitroglycerinen
dc.subjectStrokeen
dc.subjectTime Factorsen
dc.subjectLippincott Williams and Wilkinsen
dc.titleEffect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data from the ENOS Trialen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée